Back to search

Article

A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy

2019-11-27

Abstract excerpt

Vincristine is a core chemotherapeutic drug administered to pediatric acute lymphoblastic leukemia patients. Despite its efficacy in treating leukemia, it can lead to severe peripheral neuropathy in a sub-group of the patients. Peripheral neuropathy is a debilitating and painful side-effect that can severely impact an individual’s quality of life. Currently, there are no established predictors of peripheral neurop...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1e7d4066-db85-50da-b31e-f0b7b562b6de
DOI
10.1101/19013078
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral NeuropathyDOI 10.1101/19013078
Select a neighboring publication to make it the new centre.